Heart Failure Risk Heart Failure
At the Forefront of Care for Patients with Worsening Heart Failure: New and Emerging Treatment Options
Supported by an independent medical educational grant from Merck.
Survival data show ‘immense burden’ of ESKD on mortality
Compared with illnesses like cancer, heart failure and dementia, patients with end-stage kidney disease alone have among the lowest rates of survival after 5 years, Stanford University researchers reported in a published study.
Top in women’s health: Highlights from The Pregnancy meeting
Previously healthy women who delivered via cesarian had increased short-term risk for CVD complications after delivery, according to data presented at The Pregnancy Meeting.
Older adults with low creatinine, cystatin C-based eGFR at higher risk for poor outcomes
Older adults with low eGFR based on creatinine and cystatin C levels may be at higher risk for adverse events compared with those who have low eGFR based on creatinine level, data show.
Health Canada approves use of Jardiance for patients with CKD
Health Canada has approved the use of Jardiance for the treatment of adults with chronic kidney disease, according to a press release.
Addressing and Treating Iron Deficiency to Improve Symptoms and Outcomes in Patients with Heart Failure
This activity is supported by an educational grant from American Regent.
HFrEF and Worsening HF: Evolving Perspectives on Management
This activity is supported by an educational grant from Merck & Co., Inc.
CHIEF-HF
Canagliflozin (Invokana, Janssen) vs. placebo for symptom improvement in patients with HF.
RAFT-AF
Catheter ablation-based rhythm control vs. medical-based rate control in patients with AF and HF.